| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |